Rossari Biotech Limited Capital Reinvestment Ratio

Latest as of March 2025: 1.15x

Rossari Biotech Limited capital reinvestment ratio. Rossari Biotech Limited (ROSSARI) has a Capital Reinvestment Ratio of 1.15x as of March 2025, meaning it reinvests 1% of its operating cash flow (Rs1.37 Billion) in capital expenditures (Rs1.59 Billion). Check total reinvestment intensity of Rossari Biotech Limited to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

1.15x
Capex / Operating Cash Flow

Operating Cash Flow

Rs1.37 Billion
INR

Capital Expenditures

Rs1.59 Billion
INR

Data as of

Mar 2025
Most recent filing

Capital Reinvestment Ratio of Rossari Biotech Limited (2017–2025)

Capital reinvestment ratio of Rossari Biotech Limited from 2017 to 2025. This chart tracks Rossari Biotech Limited's Capital Reinvestment Ratio across 9 annual periods. Also explore net asset momentum of Rossari Biotech Limited to track the company's year-over-year net asset growth rate.

Rossari Biotech Limited Capital Reinvestment Ratio by Year (2017–2025)

Rossari Biotech Limited capital reinvestment ratio by year from 2017 to 2025. For the full cash flow conversion analysis, see Rossari Biotech Limited cash flow conversion.

Year Reinvestment Ratio Operating CF (INR) Capital Expenditures YoY Change
2025 1.15x Rs1.37 Billion Rs1.59 Billion ▼ -62.0%
2024 3.04x Rs432.55 Million Rs1.31 Billion ▲ +1306.9%
2023 0.22x Rs1.52 Billion Rs328.76 Million ▼ -83.4%
2022 1.30x Rs293.58 Million Rs382.25 Million ▲ +7.1%
2021 1.22x Rs477.67 Million Rs580.84 Million ▼ -12.2%
2020 1.39x Rs548.28 Million Rs759.71 Million ▲ +124.2%
2019 0.62x Rs711.77 Million Rs439.91 Million ▲ +13.5%
2018 0.54x Rs255.69 Million Rs139.25 Million ▼ -34.6%
2017 0.83x Rs46.95 Million Rs39.12 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow